Hojatollah Vali

In silico trials can assess the effectiveness of new therapeutic methods before clinical evaluations. In this study, we propose a computational pipeline to develop personalized digital twins of cardiac ventricles, enabling a robust characterization of ventricular passive behavior with a focus on the right ventricle (RV). Our framework was employed to simulate the hearts of three right ventricular (RV) failure patients. The estimation of biomechanical properties, coupled with finding the unloaded shapes of the ventricles, was performed by minimizing the deviation between the simulated and target RV end-diastolic pressure-volume relationships (EDPVRs). Finite element analysis (FEA) was used to model the ventricles, enabling the virtual addition of an epicardial restraint to the RV. We examined two possible definitions of the target restrained RV EDPVRs: exponential and proportional volume reductions. Bayesian optimization was utilized for both material evaluation and constraint design on a wide range of available biomaterials across varying levels of desired RV volume reduction ratios. Sensitivity analysis indicated that increasing constraint thickness or stiffness shifts the RV EDPVR curve leftward. However, this shifting stops at a specific curve, beyond which further increase in restraint thickness or stiffness cannot reduce RV volumes. A perfect RV EDPVR fit was achieved with the optimal restraint, particularly for the exponentially shifted targets. The optimal thickness increases as the desired reduction ratio rises, which also corresponds to decreased fiber stress and strain in the right ventricular free wall (RVFW). Patient-specific design of epicardial restraints can offer the most effective treatment.

Using advanced microscopy methods, we show the effects of upregulated osteopontin on the microscale morphogenesis and potential crystallinity of ripening mineral foci during bone mineralization, as a precursor to crossfibrillar mineral tessellation.

.An understanding of the structure-property relationships in protein corona build-up on nanoparticles and its impact on pharmaceutical cargo release kinetics, is crucial for tuning therapeutic efficacy of nanomedicines.

Soft tissues exhibit predominantly time-dependent mechanical behavior critical for their biological function in organs like the lungs and aorta, as they can deform and stretch at varying rates depending on their function. Collagen type I serves as the primary structural component in these tissues. The viscoelastic characteristics of such tissues, stemming from diverse energy dissipation mechanisms across various length scales, remains poorly characterized at the nanoscale. Prior experimental investigations have predominantly centered on analyzing tissue responses largely attributed to interactions between cells and fibers. Despite many studies on tissue viscoelasticity from scaffolds to single collagen fibrils, the time-dependent mechanics of collagen fibrils at the sub-fibrillar level remain poorly understood. This pioneering study employs atomic force microscopy (AFM) nano-rheometry and indentation testing to examine the viscoelastic characteristics of individual collagen type I fibrils at the ultrastructural level within distinct topographical zones, specifically focusing on gap and overlap regions. Our investigation has unveiled that collagen fibrils display a viscoelastic response that replicates the mechanical behavior of the tissue at the macroscale. Further, our findings suggest a distinct viscoelastic behavior between the gap and overlap regions, likely stemming from variances in molecular organization and cross-linking modalities within these specific sites. The results of our investigation provide unequivocal proof of the temporal dependence of mechanical properties and provides unique data to be compared to atomistic models, laying a foundation for refining the precision of macroscale models that strive to capture tissue viscoelasticity across varying length scales.

An extracellular matrix protein, fibronectin (Fn), was covalently immobilized on 316L stainless steel, L605 cobalt chromium (CoCr), and nickel titanium (NiTi) surfaces through an 11-mercaptoundecanoic acid (MUA) self-assembled monolayer (SAM) pre-formed on these surfaces. Polarization modulation infrared reflection adsorption spectroscopy (PM-IRRAS) confirmed the presence of Fn on the surfaces. The Fn monolayer attached to the SAM was found to be stable under fluid shear stress. Deconvolution of the Fn amide I band indicated that the secondary structure of Fn changes significantly upon immobilization to the SAM-functionalized metal substrate. Scanning electron microscopy and energy dispersive X-ray analysis revealed that the spacing between Fn molecules on a modified commercial stent surface is approximately 66 nm, which has been reported to be the most appropriate spacing for cell/surface interactions.

A group of biosurfactants, called rhamnolipids, have been shown to have antibacterial and antibiofilm activity against multidrug-resistant bacteria. Here, we examined the effect of rhamnolipid biosurfactants extracted from Pseudomonas aeruginosa MA01 on cell growth/viability, biofilm formation, and membrane permeability of methicillin-resistant Staphylococcus aureus (MRSA) ATCC6538 bacterial cells. The results obtained from flow cytometry analysis showed that by increasing the concentration of rhamnolipid from 30 to 120 mg/mL, the cell viability decreased by about 70%, and the cell membrane permeability increased by approximately 20%. In fact, increasing rhamnolipid concentration was directly related to cell membrane permeability and inversely related to cell survival. Microtiter plate biofilm assay and laser scanning confocal microscopy analysis revealed that rhamnolipid, at a concentration of 60 mg/mL, exerts a reducing effect on the biofilm formation of Staphylococcus aureus. Real-time PCR analysis for monitoring the relative changes in the expression of agrA, agrC, icaA, and icaD genes involved in biofilm formation and related to the quorum-sensing pathway after treatment with rhamnolipid indicated a reduced expression level of these genes, as well as sortase A gene. The results of the present study deepen our knowledge regarding the use of microbial natural products as promising candidates for therapeutic applications.

Various studies have been conducted to understand the impact of environmental pollutants on cyanobacteria due to their abundant presence in aquatic and terrestrial environments, specific morphological and physiological characteristics, and high ecological flexibility in response to environmental changes. Here, the effect of different concentrations of cadmium on two native strains of cyanobacteria, namely Synechococcus sp. HS01 and Limnothrix sp. KO01 was studied and compared with each other. In this regard, the cyanobacterial growth, pigment contents, and esterase enzyme activity were evaluated after exposure of the cells to different concentrations of cadmium (II). The toxic effects of Cd(II) on the growth rate of Limnothrix sp. KO01, even at low concentrations, tended to be higher than those for Synechococcus sp. HS01. The content of pigments decreased by an increase in Cd(II) concentration. In compliance with the cell growth, the changes occurred in pigment contents of Limnothrix sp. KO01 was more sensitive than Synechococcus sp. HS01 in the presence of different concentrations of cadmium. Flow cytometry analysis of Cd(II) effects on esterase activity of both strains after 6, 24, 48, and 72 h of exposure to Cd(II) concentrations of 9, 27, 63, and 90 μM showed that tolerance to Cd(II) toxicity in Limnothrix sp. KO01 is less than Synechococcus sp. HS01. The results obtained in this study suggest high potentials of Synechococcus sp. HS01 for heavy metal bioaccumulation due to its considerable tolerance to cadmium.

A multifunctionalized graphene oxide (GO)‐based carrier with conjugation of aminated‐polyethylene glycol (PEG‐diamine), octaarginine (R8), and folic acid (FA), which also contains chloroquine (CQ), a lysosomotropic agent, is introduced. The cellular uptake mechanisms and intracellular targeting of FA‐functionalized nanocarriers are examined. The localized releases of CQ and siRNA intracellular delivery are evaluated. Microencapsulation of the nanocarrier complexed with genes in layer‐by‐layer coating of alginate microbeads is also investigated. The covalently coconjugated FA with PEG and R8 provides a stable formulation with increased cellular uptake compared to FA‐free carrier. The CQ‐equipped nanocarrier shows a 95% release of CQ at lysosomal pH. The localized release of the drug inside the lysosomes is verified which accelerates the cargo discharge into cytoplasm.

In Drosophila melanogaster there are two genes encoding ribosomal protein S5, RpS5a and RpS5b. Here, we demonstrate that RpS5b is required for oogenesis. Females lacking RpS5b produce ovaries with numerous developmental defects that undergo widespread apoptosis in mid-oogenesis. Females lacking germline RpS5a are fully fertile, but germline expression of interfering RNA targeting germline RpS5a in an RpS5b mutant background worsened the RpS5b phenotype and blocked oogenesis before egg chambers form. A broad spectrum of mRNAs co-purified in immunoprecipitations with RpS5a, while RpS5b-associated mRNAs were specifically enriched for GO terms related to mitochondrial electron transport and cellular metabolic processes. Consistent with this, RpS5b mitochondrial fractions are depleted for proteins linked to oxidative phosphorylation and mitochondrial respiration, and RpS5b mitochondria tended to form large clusters and had more heterogeneous morphology than those from controls. We conclude that RpS5b-containing ribosomes preferentially associate with particular mRNAs and serve an essential function in oogenesis.